Amyloidosis presenting with edema and heavy proteinuria: A case report
Keywords:
Amyloidosis, heavy proteinuria, pleural and pericardial effusionAbstract
Amyloidosis is the disease caused by extra-cellular accumulation of amyloid substance within various organs leading to progressive dysfunction of the organs. The organs that are more commonly involved include the kidney and the heart. This report is aimed topresent a case of systemic amyloidosis in a 69-year-old Thai woman who presented with edema and heavy proteinuria. She was referred to our hospital because of anasarca, suspected of amyloidosis. Her underlying diseases included diabetes mellitus, hypertension, hypothyroidism and chronic kidney disease stage 4 which were regularly and well controlled with medications.The physical examination confirmed the anasarca. Her vital signs were unremarkable. The blood tests revealed Hb10.2 g%, creatinine 1.98 mg%, FBS 96 mg%, HbA1c 5.6 %, albumin 2.4 g%, globulin 3.1 g%, cholesterol 149 mg%, positive ANA, FT4 1.18 mcg/dl, FT3 1.34 ng/ml, TSH 3.916 mIU/ml. The urinalysis showed no redblood cell, no white blood cell, no sugar, protein 4+ and the calculated urine protein to creatinine ratio (UPCR) was 8.8. The chest film revealed diffuse cardiomegaly and bilateral pleural effusion. The echocardiography showed granular sparkling at the interventricular septum which was highly specific for amyloidosis of the heart and moderate pericardial effusion. The abdominal fat pad biopsy was performed and found positive for Congo red with apparent apple green birefringence under polarized microscope.She was definitely diagnosed as nephrotic syndrome because of the systemic amyloidosis involving the heart and the kidney, not due to the diabetes, hypertension or systemic lupus erythematosus. Generally amyloidosis involving the kidney mostly accumulatesthe amyloid substance within the glomerulus and less commonly in the interstitium therefore the main manifestation is proteinuria which may vary from minimally asymptomatic to heavy proteinuria, 20 - 30 gram a day, accompanied by edema. If the patients are left untreated, the disease will progress to progressive kidney impairment and mortality.
Downloads
References
Gillmore JD, Hawkins PN. Pathophysiology and treatment of systemic amyloidosis. Nat Rev Nephrol 2013;9:574-86.https://doi.org/10.1038/nrneph.2013.171
Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 2013;8:1515-23.
https://doi.org/10.2215/CJN.10491012
Kurita N, Kotera N, Ishimoto Y, Tanaka M, Tanaka S, Toda N, et al. AA amyloid nephropathy with predominant vascular deposition in Crohn's disease. Clin Nephrol 2013; 79:229-32.
https://doi.org/10.5414/CN107151
Kumar S, Dispenzieri A, Katzmann JA, Larson DR, Colby CL, Lacy MQ, et al. Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognosticvalue and correlations with clinical features. Blood 2010;116:5126-9. https://doi.org/10.1182/blood-2010-06-290668
Graziani MS, Merlini G. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions. Expert Rev Mol Diagn 2014;14:55-66.
https://doi.org/10.1586/14737159.2014.864557
Melmed GM. Light chain amyloidosis: a case presentation and review. Proc (Bayl Univ Med Cent) 2009;22:280-3. https://doi.org/10.1080/08998280.2009.11928533
Kodner C. Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician 2016; 93:479-85. https://doi.org/10.1007/978-3-662-52972-0_17
Stoycheff N, Stevens LA, Schmid CH, Tighiouart H, Lewis J, Atkins RC, et al. Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. Am J Kidney Dis 2009;54:840-9.
https://doi.org/10.1053/j.ajkd.2009.04.016
Obialo CI, Hewan-Lowe K, Fulong B. Nephrotic syndrome as a result of essential hypertension. Kidney Blood Press Res 2002;25: 250-4. https://doi.org/10.1159/000066345
Seshan SV, Jennette JC. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med 2009;133:233-48. https://doi.org/10.5858/133.2.233
Jones BA, Shapiro HS, Rosenberg BF, Bernstein J. Minimal renal amyloidosis with nephrotic syndrome. Arch Pathol Lab Med 1986; 110: 889-92.
Cohen LJ, Rennke HG, Laubach JP, Humphreys BD. The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis 2010; 56:1191-6.
https://doi.org/10.1053/j.ajkd.2010.07.009
Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006;166:1805-13. https://doi.org/10.1001/archinte.166.17.1805
Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol 1988;63:201-12. https://doi.org/10.3109/10520298809107185
Bogov B, Lubomirova M, Kiperova B. Biopsy of subcutaneous fatty tissue for diagnosis of systemic amyloidosis. Hippokratia 2008;12: 236-9.
Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006;17:3458-71.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.